Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polymorphic N-acetylation capacity in lung cancer.

P A Philip1, D L Fitzgerald, R A Cartwright

  • 1Department of Medical Oncology, Charing Cross Hospital, London.

Carcinogenesis
|March 1, 1988
PubMed
Summary

This study found no link between N-acetylation capacity and lung cancer risk. Acetylation phenotypes did not differ between lung cancer patients and controls, nor among histological subtypes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying and exploring patient engagement interventions for people diagnosed with lung cancer: A rapid systematic review.

Lung cancer (Amsterdam, Netherlands)·2025
Same author

A qualitative exploration of barriers and facilitators to inclusion of dentistry in a regional shared health care record.

Community dental health·2024
Same author

ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer.

medRxiv : the preprint server for health sciences·2024
Same author

Geographical Variation in Underlying Social Deprivation, Cardiovascular and Other Comorbidities in Patients with Potentially Curable Cancers in England: Results from a National Registry Dataset Analysis.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

Adolescent valuation of CARIES-QC-U: a child-centred preference-based measure of dental caries.

Health and quality of life outcomes·2022
Same author

Targeting B cells in pancreatic adenocarcinoma: does RESOLVE resolve the question?

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Area of Science:

  • Pharmacogenomics
  • Oncology
  • Metabolic enzyme activity

Background:

  • Hepatic N-acetylation phenotype is implicated in bladder cancer etiology.
  • Understanding acetylation's role in other cancers, like lung cancer, is crucial.

Purpose of the Study:

  • To investigate the association between N-acetylation capacity and lung cancer.
  • To determine if acetylation phenotypes differ in lung cancer patients versus controls.

Main Methods:

  • Case-control study design.
  • Analysis of N-acetylation phenotypes in 126 lung cancer cases and two control groups.
  • Comparison of acetylation phenotype distribution across groups and histological subtypes.

Main Results:

Related Experiment Videos

  • No significant overall association was found between slow or rapid acetylator phenotypes and lung cancer.
  • Acetylation phenotype distribution showed no difference between lung cancer patients and control groups.
  • No variation in acetylation phenotypes was observed among different lung cancer histological subtypes.

    • Conclusions:

    • Hepatic N-acetylation capacity does not appear to be a risk factor for lung cancer.
    • Acetylation phenotype is unlikely to influence lung cancer susceptibility or histological classification.